MarkWayneBallMDFACS

Minimally Invasive Surgery, Surgical Oncology

Associate Professor. Associate Program Director, Urologic Oncology Fellowship, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Join to view full profile

Dr. Ball is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ball's full profile

Already have an account?

Office
10 Center Drive
Bethesda, MD 20892

Summary

Dr. Mark Ball is a board-certified urologist in Bethesda, MD and is affiliated with National Institutes of Health Clinical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 7 years. He specializes in minimally invasive surgery and surgical oncology and is experienced in kidney cancer, adrenal surgery, and retroperitoneal lymph node dissection.

Education & Training

National Institutes of Health Clinical CenterFellowship, Urologic Surgical Oncology, 2016 - 2018
Johns Hopkins UniversityResidency, Urology, 2011 - 2016
Johns Hopkins UniversityInternship, Surgery, 2010 - 2011
Johns Hopkins University School of MedicineClass of 2010

Certifications & Licensure

MD State Medical License 2013 - 2026
DC State Medical License 2017 - 2018
American Board of Urology Urology

Awards, Honors, & Recognition

Resident Teaching Award Department of Urology, Johns Hopkins University, 2016
Alpha Omega Alpha Medical Honor Society 2015
Member Alpha Omega Alpha, 2014
Outstanding Laparoendoscopic Resident Surgeon Award Johns Hopkins Hopsital, 2013
House Staff Teaching Award Johns Hopkins School of Medicine, 2012
Outstanding Junior Resident Teacher Department of Surgery, Johns Hopkins University, 2011
Member Phi Beta Kappa, 2010
Join now to see all

Clinical Trials

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Start of enrollment: 2010 May 06
Active, not recruiting
Phase 2
Robot-Assisted MRI-Guided Prostate Biopsy Start of enrollment: 2013 Jul 25
Completed
Not Applicable
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma Start of enrollment: 2014 May 01
Completed
Not Applicable
The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry Start of enrollment: 2009 Jan 01
Recruiting
PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma Start of enrollment: 2017 Apr 24
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Imaging finding of renal masses associated with pathogenic variation in succinate dehydrogenase subunit B gene.
Aditi Chaurasia, Evrim B Turkbey, Fatemeh Dehghani Firouzabadi, Shiva Singh, Safa Samimi
Clinical Imaging. 2024-11-01
A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau disease.
Cathy D Vocke, Christopher J Ricketts, Svetlana Pack, Mark Raffeld, Stephen Hewitt
Journal of Medical Genetics. 2024-10-23
Predicting post-surgical complications using renal scoring systems.
Mahshid Golagha, Charles Hesswani, Shiva Singh, Fatemeh Dehghani Firouzabadi, Ali Sheikhy
Abdominal Radiology. 2024-10-12

Press Mentions

Decision Making During Complex Partial Nephrectomy: A Guidelines-Based ApproachMarch 21st, 2021
AUA 2018: Kidney Cancer Tumor BoardMay 19th, 2018
SUO 2017: Results on Active Surveillance for Von Hippel-Lindau-Related Renal Tumors Using Size-Based Risk StratificationDecember 3rd, 2017
Join now to see all

Grant Support

Clinical Research GrantIntuitive Surgery2013–2014
GrantSexual Medicine Society of North America2010–2012

Research History

Fellow, Urologic OncologyLaboratory of W. Marson Linehan, MD. Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute2016 - 2018
Research FellowJames Buchanan Brady Urological Institute2013 - 2014